Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial
Luvira et al., BMC Infectious Diseases, doi:10.1186/s12879-023-08835-3 (date from preprint)
https://c19early.org/luvira.html